The following trends in 2020 were identified in Europe:
- Financing volumes in the European Life Sciences sector have reached a new record high of approximately EUR 8.6bn in 2020 (an increase of +38% compared to 2019) while the number of deals have slightly decreased
- UK continued to record the most transactions and highest volumes throughout the last 5 years
- In 2020, the biotechnology sector leads with EUR 5.3bn, by far, in aggregated deal volumes, however, the medical technology sector has recorded the highest number of deals (465)
- Oncology was again the most targeted indication within the biotechnology sector in 2020 (96 deals), followed by Infectious Diseases with 35 deals
- With a financing volume of EUR 560m, CureVac is leading the top 10 European Life Sciences Deals in 2020
- Cross-border investors tend to play a more important role, especially in later stage rounds, with the US being the most important cross-border investor in Europe
Capital Markets Research
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector
Healthcare & Life Sciences Venture Capital Monitor – USAMonthly Venture capital activities in the US Life Sciences sector
NEWS
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 10/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 09/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 09/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 09/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 08/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 08/2024”. The Monitor is a monthly published overview of venture capital trends in
